Literature DB >> 22832103

Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.

Hsien-Yang Lee1, Yong Huang, Nadine Bruneau, Patrice Roll, Elisha D O Roberson, Mark Hermann, Emily Quinn, James Maas, Robert Edwards, Tetsuo Ashizawa, Betul Baykan, Kailash Bhatia, Susan Bressman, Michiko K Bruno, Ewout R Brunt, Roberto Caraballo, Bernard Echenne, Natalio Fejerman, Steve Frucht, Christina A Gurnett, Edouard Hirsch, Henry Houlden, Joseph Jankovic, Wei-Ling Lee, David R Lynch, Shehla Mohammed, Ulrich Müller, Mark P Nespeca, David Renner, Jacques Rochette, Gabrielle Rudolf, Shinji Saiki, Bing-Wen Soong, Kathryn J Swoboda, Sam Tucker, Nicholas Wood, Michael Hanna, Anne M Bowcock, Pierre Szepetowski, Ying-Hui Fu, Louis J Ptáček.   

Abstract

Paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) is an episodic movement disorder with autosomal-dominant inheritance and high penetrance, but the causative genetic mutation is unknown. We have now identified four truncating mutations involving the gene PRRT2 in the vast majority (24/25) of well-characterized families with PKD/IC. PRRT2 truncating mutations were also detected in 28 of 78 additional families. PRRT2 encodes a proline-rich transmembrane protein of unknown function that has been reported to interact with the t-SNARE, SNAP25. PRRT2 localizes to axons but not to dendritic processes in primary neuronal culture, and mutants associated with PKD/IC lead to dramatically reduced PRRT2 levels, leading ultimately to neuronal hyperexcitability that manifests in vivo as PKD/IC.
Copyright © 2012 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22832103      PMCID: PMC3334308          DOI: 10.1016/j.celrep.2011.11.001

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  44 in total

1.  A human protein-protein interaction network: a resource for annotating the proteome.

Authors:  Ulrich Stelzl; Uwe Worm; Maciej Lalowski; Christian Haenig; Felix H Brembeck; Heike Goehler; Martin Stroedicke; Martina Zenkner; Anke Schoenherr; Susanne Koeppen; Jan Timm; Sascha Mintzlaff; Claudia Abraham; Nicole Bock; Silvia Kietzmann; Astrid Goedde; Engin Toksöz; Anja Droege; Sylvia Krobitsch; Bernhard Korn; Walter Birchmeier; Hans Lehrach; Erich E Wanker
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

2.  16p11.2-related paroxysmal kinesigenic dyskinesia and dopa-responsive parkinsonism in a child.

Authors:  Jonathan Lipton; Michael J Rivkin
Journal:  Neurology       Date:  2009-08-11       Impact factor: 9.910

3.  Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia.

Authors:  Hsien-yang Lee; Junko Nakayama; Ying Xu; Xueliang Fan; Maha Karouani; Yiguo Shen; Emmanuel N Pothos; Ellen J Hess; Ying-Hui Fu; Robert H Edwards; Louis J Ptácek
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

4.  Diabetes mellitus presenting as paroxysmal kinesigenic dystonic choreoathetosis.

Authors:  J D Clark; R Pahwa; C Koller; D Morales
Journal:  Mov Disord       Date:  1995-05       Impact factor: 10.338

5.  Paroxysmal kinesigenic choreoathetosis (PKC): confirmation of linkage to 16p11-q21, but unsuccessful detection of mutations among 157 genes at the PKC-critical region in seven PKC families.

Authors:  Taeko Kikuchi; Masayo Nomura; Hiroaki Tomita; Naoki Harada; Kazuaki Kanai; Tohru Konishi; Ayako Yasuda; Masato Matsuura; Nobumasa Kato; Koh-Ichiro Yoshiura; Norio Niikawa
Journal:  J Hum Genet       Date:  2007-02-14       Impact factor: 3.172

6.  GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak.

Authors:  Yvonne G Weber; Alexander Storch; Thomas V Wuttke; Knut Brockmann; Judith Kempfle; Snezana Maljevic; Lucia Margari; Christoph Kamm; Susanne A Schneider; Stephan M Huber; Arnulf Pekrun; Robert Roebling; Guiscard Seebohm; Saisudha Koka; Camelia Lang; Eduard Kraft; Dragica Blazevic; Alberto Salvo-Vargas; Michael Fauler; Felix M Mottaghy; Alexander Münchau; Mark J Edwards; Anna Presicci; Francesco Margari; Thomas Gasser; Florian Lang; Kailash P Bhatia; Frank Lehmann-Horn; Holger Lerche
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  Infantile convulsions with paroxysmal dyskinesia (ICCA syndrome) and copy number variation at human chromosome 16p11.

Authors:  Patrice Roll; Damien Sanlaville; Jennifer Cillario; Audrey Labalme; Nadine Bruneau; Annick Massacrier; Marc Délepine; Philippe Dessen; Vladimir Lazar; Andrée Robaglia-Schlupp; Gaëtan Lesca; Elisabeth Jouve; Gabrielle Rudolf; Jacques Rochette; G Mark Lathrop; Pierre Szepetowski
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

8.  Topiramate therapy for paroxysmal kinesigenic choreoathetosis.

Authors:  Yuan-Gui Huang; Yun-Chun Chen; Fang Du; Rui Li; Ge-Lin Xu; Wen Jiang; Jing Huang
Journal:  Mov Disord       Date:  2005-01       Impact factor: 10.338

9.  Benign familial infantile convulsions: linkage to chromosome 16p12-q12 in 14 families.

Authors:  Yvonne G Weber; Andrea Berger; Nerses Bebek; Sabine Maier; Skevos Karafyllakes; Nancy Meyer; Yukio Fukuyama; Anne Halbach; Christiane Hikel; Gerhard Kurlemann; Bernd Neubauer; Makiko Osawa; Burkhard Püst; Dietz Rating; Kayoko Saito; Ulrich Stephani; Ulrike Tauer; Frank Lehmann-Horn; Karin Jurkat-Rott; Holger Lerche
Journal:  Epilepsia       Date:  2004-06       Impact factor: 5.864

10.  Integrative genomics viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Wendy Winckler; Mitchell Guttman; Eric S Lander; Gad Getz; Jill P Mesirov
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

View more
  92 in total

1.  Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes.

Authors:  Julian Schubert; Aleksandra Siekierska; Mélanie Langlois; Patrick May; Clément Huneau; Felicitas Becker; Hiltrud Muhle; Arvid Suls; Johannes R Lemke; Carolien G F de Kovel; Holger Thiele; Kathryn Konrad; Amit Kawalia; Mohammad R Toliat; Thomas Sander; Franz Rüschendorf; Almuth Caliebe; Inga Nagel; Bernard Kohl; Angela Kecskés; Maxime Jacmin; Katia Hardies; Sarah Weckhuysen; Erik Riesch; Thomas Dorn; Eva H Brilstra; Stephanie Baulac; Rikke S Møller; Helle Hjalgrim; Bobby P C Koeleman; Karin Jurkat-Rott; Frank Lehman-Horn; Jared C Roach; Gustavo Glusman; Leroy Hood; David J Galas; Benoit Martin; Peter A M de Witte; Saskia Biskup; Peter De Jonghe; Ingo Helbig; Rudi Balling; Peter Nürnberg; Alexander D Crawford; Camila V Esguerra; Yvonne G Weber; Holger Lerche
Journal:  Nat Genet       Date:  2014-11-02       Impact factor: 38.330

2.  Common DNA methylation alterations in multiple brain regions in autism.

Authors:  C Ladd-Acosta; K D Hansen; E Briem; M D Fallin; W E Kaufmann; A P Feinberg
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

3.  Mild paroxysmal kinesigenic dyskinesia caused by PRRT2 missense mutation with reduced penetrance.

Authors:  Jennifer Friedman; Jesus Olvera; Jennifer L Silhavy; Stacey B Gabriel; Joseph G Gleeson
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

4.  Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder.

Authors:  Noa Lipstein; Nanda M Verhoeven-Duif; Francesco E Michelassi; Nathaniel Calloway; Peter M van Hasselt; Katarzyna Pienkowska; Gijs van Haaften; Mieke M van Haelst; Ron van Empelen; Inge Cuppen; Heleen C van Teeseling; Annemieke M V Evelein; Jacob A Vorstman; Sven Thoms; Olaf Jahn; Karen J Duran; Glen R Monroe; Timothy A Ryan; Holger Taschenberger; Jeremy S Dittman; Jeong-Seop Rhee; Gepke Visser; Judith J Jans; Nils Brose
Journal:  J Clin Invest       Date:  2017-02-13       Impact factor: 14.808

Review 5.  Genetic biomarkers in epilepsy.

Authors:  Yvonne G Weber; Anne T Nies; Matthias Schwab; Holger Lerche
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

6.  The Role of PRRT2 in Synaptic Transmission May Not Be So Benign.

Authors:  Matthew C Weston
Journal:  Epilepsy Curr       Date:  2017 May-Jun       Impact factor: 7.500

7.  Paroxysmal Kinesigenic Dyskinesia May Be Misdiagnosed in Co-occurring Gilles de la Tourette Syndrome.

Authors:  Christos Ganos; Niccolo Mencacci; Alice Gardiner; Roberto Erro; Amit Batla; Henry Houlden; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

8.  Altered intrinsic brain activity in patients with paroxysmal kinesigenic dyskinesia by PRRT2 mutation: altered brain activity by PRRT2 mutation.

Authors:  ChunYan Luo; Yongping Chen; Wei Song; Qin Chen; QiYong Gong; Hui-Fang Shang
Journal:  Neurol Sci       Date:  2013-03-27       Impact factor: 3.307

Review 9.  Next-generation sequencing diagnostics for neurological diseases/disorders: from a clinical perspective.

Authors:  Jia Nee Foo; Jianjun Liu; Eng-King Tan
Journal:  Hum Genet       Date:  2013-03-23       Impact factor: 4.132

10.  PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine.

Authors:  Robin Cloarec; Nadine Bruneau; Gabrielle Rudolf; Annick Massacrier; Manal Salmi; Marc Bataillard; Clotilde Boulay; Roberto Caraballo; Natalio Fejerman; Pierre Genton; Edouard Hirsch; Alasdair Hunter; Gaetan Lesca; Jacques Motte; Agathe Roubertie; Damien Sanlaville; Sau-Wei Wong; Ying-Hui Fu; Jacques Rochette; Louis J Ptácek; Pierre Szepetowski
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.